Coronavirus

News

First doses of Gilead's COVID-19 drug remdesivir to arrive a...

The first doses of Gilead’s COVID-19 drug remdesivir are set to arrive in US hospitals this week after the FDA said the medicine can be used to fight the coronavirus pandemic.

Views & Analysis

How virtual conferences are faring and how pharma can do better

What pharma can do to win in virtual

Early data indications from the first virtual congresses shows big changes are needed.

News

Amgen to test psoriasis pill Otezla in COVID-19

Amgen has announced it is developing its already marketed psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the SARS-CoV-2 coronavirus.

News

Covid-19 drug will be 'affordable' says Gilead, as it plans ...

Gilead has outlined its plans to develop and ramp up production of its remdesivir COVID-19 drug, with CEO Daniel O’Day pledging to ensure it is affordable after phase 3 results showed it cu

Views & Analysis

Coronavirus pharma news roundup – 1/5/2020

This week saw several pharma companies reveal how the coronavirus pandemic has affected their sales.

News

AZ joins COVID-19 vaccine race with Oxford Uni partnership

AstraZeneca has joined with Oxford University to develop and distribute the institution’s potential coronavirus vaccine, ahead of an early trial readout as soon as June or July.

First doses of Gilead's COVID-19 drug remdesivir to arrive a...

What pharma can do to win in virtual

Amgen to test psoriasis pill Otezla in COVID-19

Covid-19 drug will be 'affordable' says Gilead, as it plans ...

Coronavirus pharma news roundup – 1/5/2020

AZ joins COVID-19 vaccine race with Oxford Uni partnership

Gilead strikes again, penning $5bn deal to buy Tubulis

Using AI-driven synthetic personas to take your insights fur...

Coronavirus

Editor's Picks